Literature DB >> 24395070

Survival outcomes and prognostic factors of surgical therapy for all potentially resectable intrahepatic cholangiocarcinoma: a large single-center cohort study.

Xianwu Luo1, Lei Yuan, Yi Wang, Ruiliang Ge, Yanfu Sun, Gongtian Wei.   

Abstract

BACKGROUND: Surgical resection is currently indicated for all potentially resectable intrahepatic cholangiocarcinoma (ICC), but the survival outcomes and the prognostic factors have not been well-documented due to its rarity. This study aims to assess these in a large, consecutive series of patients with ICC treated surgically.
METHODS: A retrospective study was conducted on 1,333 ICC patients undergoing surgery between January 2007 and December 2011. Surgical results and survival were evaluated and compared among different subgroups of patients. Univariate and multivariate analyses were performed to identify prognostic factors.
RESULTS: R0, R1, R2 resection and exploratory laparotomy were obtained in 34.8, 44.9, 16.4, and 3.9% of the patients, respectively. The overall 1-, 3-, and 5-year survival rates for the entire cohort were 58.2, 25.2, and 17.0%, respectively, with corresponding rates of 79.1, 42.6, and 28.7% for patients with R0 resection; 60.5, 20.1, and 13.9% for patients with R1 resection; 20.5, 7.4, and 0% for patients with R2 resection; and 3.8, 0, and 0% for patients with an exploratory laparotomy. Independent factors for poor survival included positive resection margin, lymph node metastasis, multiple tumors, vascular invasion, and elevated CA19-9 and/or CEA, whereas hepatitis B virus infection and cirrhosis were independently favorable prognosis indicators.
CONCLUSIONS: R0 resection offers the best possibility of long-term survival, but the chance of a R0 resection is low when surgery is performed for potential resectable ICC. Further randomized trials are warranted to refine indications for surgery in the management of ICC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24395070     DOI: 10.1007/s11605-013-2447-3

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  50 in total

1.  Impact of nodal involvement on surgical outcomes of intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Authors:  Kazuhisa Uchiyama; Masakazu Yamamoto; Hiroki Yamaue; Shun-ichi Ariizumi; Taku Aoki; Norihiro Kokudo; Tomoki Ebata; Masato Nagino; Masayuki Ohtsuka; Masaru Miyazaki; Eiichi Tanaka; Satoshi Kondo; Takahiro Uenishi; Shoji Kubo; Hiroshi Yoshida; Michiaki Unno; Satoru Imura; Mitsuo Shimada; Masaki Ueno; Tadahiro Takada
Journal:  J Hepatobiliary Pancreat Sci       Date:  2011-05       Impact factor: 7.027

Review 2.  Staging of intrahepatic cholangiocarcinoma.

Authors:  Hari Nathan; Timothy M Pawlik
Journal:  Curr Opin Gastroenterol       Date:  2010-05       Impact factor: 3.287

3.  Fifteen-year, single-center experience with the surgical management of intrahepatic cholangiocarcinoma: operative results and long-term outcome.

Authors:  Manousos M Konstadoulakis; Sasan Roayaie; Ilias P Gomatos; Daniel Labow; Maria-Isabell Fiel; Charles M Miller; Myron E Schwartz
Journal:  Surgery       Date:  2007-12-21       Impact factor: 3.982

4.  A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables.

Authors:  T Okabayashi; J Yamamoto; T Kosuge; K Shimada; S Yamasaki; T Takayama; M Makuuchi
Journal:  Cancer       Date:  2001-11-01       Impact factor: 6.860

5.  Hepatitis B virus infection: a favorable prognostic factor for intrahepatic cholangiocarcinoma after resection.

Authors:  Hua-Bang Zhou; Hui Wang; Yu-Qiong Li; Shuang-Xi Li; Hao Wang; Dong-Xun Zhou; Qian-Qian Tu; Qing Wang; Shan-Shan Zou; Meng-Chao Wu; He-Ping Hu
Journal:  World J Gastroenterol       Date:  2011-03-14       Impact factor: 5.742

6.  Prognostic value of cirrhosis for intrahepatic cholangiocarcinoma after surgical treatment.

Authors:  Ya-yong Li; Hao Li; Pin Lv; Gang Liu; Xiao-rong Li; Bu-ning Tian; Dao-jin Chen
Journal:  J Gastrointest Surg       Date:  2011-01-19       Impact factor: 3.452

7.  Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index.

Authors:  Ken Shirabe; Yohei Mano; Akinobu Taketomi; Yuji Soejima; Hideaki Uchiyama; Shinichi Aishima; Hiroto Kayashima; Mizuki Ninomiya; Yoshihiko Maehara
Journal:  Ann Surg Oncol       Date:  2010-02-05       Impact factor: 5.344

8.  Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution.

Authors:  Michelle L DeOliveira; Steven C Cunningham; John L Cameron; Farin Kamangar; Jordan M Winter; Keith D Lillemoe; Michael A Choti; Charles J Yeo; Richard D Schulick
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

9.  Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcomes.

Authors:  S Roayaie; J V Guarrera; M Q Ye; S N Thung; S Emre; T M Fishbein; S R Guy; P A Sheiner; C M Miller; M E Schwartz
Journal:  J Am Coll Surg       Date:  1998-10       Impact factor: 6.113

10.  Patient outcome and prognostic factors in intrahepatic cholangiocarcinoma after hepatectomy.

Authors:  Atsushi Nanashima; Yorihisa Sumida; Takafumi Abo; Toshiya Nagasaki; Hiroaki Takeshita; Hidetoshi Fukuoka; Terumitsu Sawai; Kenji Tanaka; Toru Yasutake; Takeshi Nagayasu
Journal:  Hepatogastroenterology       Date:  2007-12
View more
  42 in total

1.  Intrahepatic cholangiocarcinoma: expert consensus statement.

Authors:  Sharon M Weber; Dario Ribero; Eileen M O'Reilly; Norihiro Kokudo; Masaru Miyazaki; Timothy M Pawlik
Journal:  HPB (Oxford)       Date:  2015-08       Impact factor: 3.647

2.  Intensity-modulated radiotherapy following null-margin resection is associated with improved survival in the treatment of intrahepatic cholangiocarcinoma.

Authors:  Angela Y Jia; Jian-Xiong Wu; Yu-Ting Zhao; Ye-Xiong Li; Zhi Wang; Wei-Qi Rong; Li-Ming Wang; Jing Jin; Shu-Lian Wang; Yong-Wen Song; Yue-Ping Liu; Hua Ren; Hui Fang; Wen-Qing Wang; Xin-Fan Liu; Zi-Hao Yu; Wei-Hu Wang
Journal:  J Gastrointest Oncol       Date:  2015-04

3.  Oncologic Impact of Lymph Node Dissection for Intrahepatic Cholangiocarcinoma: a Propensity Score-Matched Study.

Authors:  Sung Hyun Kim; Dai Hoon Han; Gi Hong Choi; Jin Sub Choi; Kyung Sik Kim
Journal:  J Gastrointest Surg       Date:  2018-08-15       Impact factor: 3.452

Review 4.  Intrahepatic cholangiocarcinoma and cholangiolocellular carcinoma in cirrhosis and chronic viral hepatitis.

Authors:  Shun-ichi Ariizumi; Masakazu Yamamoto
Journal:  Surg Today       Date:  2014-09-25       Impact factor: 2.549

Review 5.  Monitoring outcomes in intrahepatic cholangiocarcinoma patients following hepatic resection.

Authors:  Amir A Rahnemai-Azar; Pallavi Pandey; Ihab Kamel; Timothy M Pawlik
Journal:  Hepat Oncol       Date:  2017-01-20

6.  Survival outcomes and progonostic factors of extrahepatic cholangiocarcinoma patients following surgical resection: Adjuvant therapy is a favorable prognostic factor.

Authors:  Haixia Yang; Jiupeng Zhou; Xin Wei; Fan Wang; Huadong Zhao; Enxiao Li
Journal:  Mol Clin Oncol       Date:  2014-08-07

7.  Prognostic Impact of Tumor Growth Type on 7th AJCC Staging System for Intrahepatic Cholangiocarcinoma: a Single-Center Experience of 659 Cases.

Authors:  Shin Hwang; Young-Joo Lee; Gi-Won Song; Kwang-Min Park; Ki-Hun Kim; Chul-Soo Ahn; Deok-Bog Moon; Sung-Gyu Lee
Journal:  J Gastrointest Surg       Date:  2015-03-28       Impact factor: 3.452

8.  Low Incidence of Lymph Node Metastasis After Resection of Hepatitis Virus-Related Intrahepatic Cholangiocarcinoma.

Authors:  Hiroya Iida; Masaki Kaibori; Shogo Tanaka; Shigekazu Takemura; Hiroshi Wada; Fumitoshi Hirokawa; Takuya Nakai; Michihiro Hayashi; Hidetoshi Eguchi; Shoji Kubo
Journal:  World J Surg       Date:  2017-04       Impact factor: 3.352

9.  MTSS1 is an independent prognostic biomarker for survival in intrahepatic cholangiocarcinoma patients.

Authors:  Wei Shi; Gulimire Hasimu; Yan Wang; Ning Li; Mingquan Chen; Hao Zhang
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

Review 10.  Hepatitis B virus and hepatitis C virus play different prognostic roles in intrahepatic cholangiocarcinoma: A meta-analysis.

Authors:  Zheng Wang; Yuan-Yuan Sheng; Qiong-Zhu Dong; Lun-Xiu Qin
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.